spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  chronic sinusitis 

 HSMN NewsFeed - 20 Jul 2016
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
Devices Interventional Product Launch
 HSMN NewsFeed - 19 Jul 2016
Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP(TM) Allergy Testing Products
Diagnostics Product Launch
 HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
Devices FDA
 HSMN NewsFeed - 13 Apr 2016
Oculus Innovative Sciences Receives European Approval to Market Sinudox(TM) Indicated for Use in Nasal Irrigation
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Feb 2015
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
Devices Product Launch
 HSMN NewsFeed - 17 Feb 2014
New Study Affirms In-Office Multi-Sinus Balloon Dilation is an Effective, Well Tolerated Treatment Option for Chronic Sinusitis Sufferers
Devices
 HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Devices FDA
 HSMN NewsFeed - 21 Nov 2013
Thomas J. Fogarty, M.D. Joins SinuSys(TM) Corp. Board of Directors
Devices Venture Capital Personnel
 HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Devices Otolaryngology
 HSMN NewsFeed - 30 Sep 2013
Entellus Medical & CogENT Therapeutics Announce Distribution Agreement
Devices Distribution
 HSMN NewsFeed - 11 Sep 2013
Entellus Medical Launches Cordless Trans-illumination Product for Use with the XprESS LoProfile Balloon Multi-Sinus Dilation Device for the Treatment of Sinusitis
Devices Product Launch
 HSMN NewsFeed - 30 Jul 2013
Edimer Secures $18M Series B Financing Led by New Enterprise Associates
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Jul 2013
Study Shows Benefits of Balloon Sinus Dilation versus Traditional Sinus Surgery for Chronic Sinusitis
Devices
 HSMN NewsFeed - 18 Mar 2013
SinuSys Corp. Expands Executive Team
Devices Personnel
 HSMN NewsFeed - 25 Feb 2013
Intersect ENT Raises $30 Million
Devices Venture Capital
 HSMN NewsFeed - 6 Nov 2012
Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery
Devices Drug Delivery
 HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
Devices Interventional FDA Regulatory
 HSMN NewsFeed - 23 Sep 2011
Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Apr 2011
Entellus Medical(TM) Study Demonstrates XprESS(TM) Multi-Sinus Dilation Tool Safe and Effective in Treatment of Chronic Sinusitis
Devices
 HSMN NewsFeed - 23 Feb 2011
Entellus Medical(TM) Receives FDA 510(k) Clearance for FinESS(TM) Endoscope
Devices FDA
 HSMN NewsFeed - 28 Apr 2010
Entellus Medical(R) Launches the XprESS Multi-Sinus Dilation Tool at COSM 2010 Annual Meeting
Devices
 HSMN NewsFeed - 7 Apr 2010
Medtronic Launches New Frontal Handpiece for Its Hydrodebrider System
Devices
 HSMN NewsFeed - 2 Mar 2010
New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
Devices
 HSMN NewsFeed - 5 Feb 2010
Study Suggests Slide-On(R) EndoSheath(R) System Provides Several Advantages over Traditional Germicidal Immersion
Devices
 HSMN NewsFeed - 16 Dec 2009
Ethicon Announces Definitive Agreement to Acquire Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Nov 2009
Entellus Medical(R) Secures $30 Million Financing To Expand Commercialization of Novel Treatments for Sinusitis
Devices Venture Capital
 HSMN NewsFeed - 4 May 2009
Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
Devices
 HSMN NewsFeed - 12 Jan 2009
Acclarent, Inc. Closes $26 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 22 Sep 2008
Entellus Medical(R) Launches FinESS(TM) Sinus Treatment at American Academy of Otolaryngology (AAO) Annual Meeting
Devices
 HSMN NewsFeed - 22 Sep 2008
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
Devices
 HSMN NewsFeed - 14 Apr 2008
Studies Confirm Balloon Sinuplasty(TM) Helps Chronic Sinusitis Patients
Devices
 HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2007
New Medical Device and Irrigation Solution Exhibits Promising Results in the Removal of Bacterial Colonization in Chronic Sinus Infections
Devices
 HSMN NewsFeed - 8 Oct 2007
Accentia Biopharmaceuticals Announces Completion of Enrollment in Fast-Tracked Pivotal Phase 3 Clinical Trial of SinuNase for Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2007
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2007
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
Devices
 HSMN NewsFeed - 25 Jun 2007
Naryx Pharma, Inc. Announces the Appointment of Andy H. Strayer, Pharm.D. as Vice President of Clinical Operations and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2007
Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2007
New Medical Device and Irrigation Solution Exhibits Promising Results in the Removal of Bacterial Colonization in Chronic Sinus and Ear Infections
Devices
 HSMN NewsFeed - 16 Apr 2007
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Dec 2006
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2006
Naryx Pharma, Inc. Announces the Election of Geron Corporation Executive Alan B. Colowick to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2006
Accentia Biopharmaceuticals Commences Fast-Tracked Phase 3 Clinical Trial of SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2006
New Landmark Study Shows the Use of a BiovaxID Formulation Improves Disease Free survival in 80% of Patients Whose Cancer has Relapsed after Chemotherapy Administered With or Without Rituxan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2006
Multi-Center Study Confirms Balloon Sinuplasty(TM) Technology Is Safe and Effective
Devices Otolaryngology
 HSMN NewsFeed - 14 Jun 2006
Accentia Biopharmaceuticals Launches MD Turbo(TM) in the United States
Devices Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 24 May 2006
Association Between Molecular Remission and Disease-Free Survival in Non-Hodgkins Lymphoma at Over Nine Years Follow-Up To Be Presented
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2006
FDA Gives Permission to Use Very Sensitive Molecular Evidence of Cancer in BiovaxID Pivotal Phase 3 Clinical Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 May 2006
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 May 2006
Biovest's AutovaxID(TM) Cleared for Commercial Sale
Biopharmaceuticals Devices FDA
 HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Apr 2006
National Survey of U.S. Otolaryngologists First to Measure Dissatisfaction with Current Treatments for Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2006
FDA Grants Accentia Biopharmaceuticals Fast Track Status for SinuNase(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2006
Biovest International Submits Amendment Request to FDA for Use of Molecular Remission Data in the Ongoing Pivotal Phase 3 Study to Support Accelerated, Conditional Approval of BiovaxID (TM), a Personalized Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Feb 2006
SinuNase(TM) IND On Track
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
chronic sinusitis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.